Serum Glutathione in Patients with Schizophrenia in Dynamics of Antipsychotic Therapy; Bulletin of Experimental Biology and Medicine; Vol. 160, iss. 2

Detalles Bibliográficos
Parent link:Bulletin of Experimental Biology and Medicine: Scientific Journal
Vol. 160, iss. 2.— 2016.— [P. 283–285]
Autor Corporativo: Национальный исследовательский Томский политехнический университет Институт неразрушающего контроля Кафедра экологии и безопасности жизнедеятельности
Otros Autores: Ivanova S. A. Svetlana Aleksandrovna, Smirnova L. P., Shchigoreva Y. G. Yuliya Gennadjevna, Semke A. V. Arkady Valentinovich, Bokhan N. A. Nikolay Aleksandrovich
Sumario:Title screen
Serum concentrations of oxidized and reduced glutathione were measured in 73 patients with schizophrenia at admission and in dynamics of therapy with traditional and atypical antipsychotic drugs. The level of reduced glutathione in patients with schizophrenia with manifest clinical symptoms was lower than in normal subjects. Atypical neuroleptics produced virtually no effects on the glutathione system, while therapy with typical antipsychotics led to further decrease in the levels of reduced glutathione, thus aggravating the imbalance of metabolic processes typical of schizophrenia.
Режим доступа: по договору с организацией-держателем ресурса
Lenguaje:inglés
Publicado: 2016
Materias:
Acceso en línea:http://dx.doi.org/10.1007/s10517-015-3151-y
Formato: Electrónico Capítulo de libro
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=649823

MARC

LEADER 00000naa0a2200000 4500
001 649823
005 20250307111025.0
035 |a (RuTPU)RU\TPU\network\14993 
035 |a RU\TPU\network\14618 
090 |a 649823 
100 |a 20160825d2016 k||y0rusy50 ba 
101 0 |a eng 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Serum Glutathione in Patients with Schizophrenia in Dynamics of Antipsychotic Therapy  |f S. A. Ivanova [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: p. 285 (15 tit.)] 
330 |a Serum concentrations of oxidized and reduced glutathione were measured in 73 patients with schizophrenia at admission and in dynamics of therapy with traditional and atypical antipsychotic drugs. The level of reduced glutathione in patients with schizophrenia with manifest clinical symptoms was lower than in normal subjects. Atypical neuroleptics produced virtually no effects on the glutathione system, while therapy with typical antipsychotics led to further decrease in the levels of reduced glutathione, thus aggravating the imbalance of metabolic processes typical of schizophrenia. 
333 |a Режим доступа: по договору с организацией-держателем ресурса 
461 |t Bulletin of Experimental Biology and Medicine  |o Scientific Journal 
463 |t Vol. 160, iss. 2  |v [P. 283–285]  |d 2016 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
701 1 |a Ivanova  |b S. A.  |c specialist in the field of ecology and life safety  |c Professor of Tomsk Polytechnic University, doctor of medical sciences  |f 1964-  |g Svetlana Aleksandrovna  |3 (RuTPU)RU\TPU\pers\33859  |9 17448 
701 1 |a Smirnova  |b L. P. 
701 1 |a Shchigoreva  |b Y. G.  |g Yuliya Gennadjevna 
701 1 |a Semke  |b A. V.  |g Arkady Valentinovich 
701 1 |a Bokhan  |b N. A.  |g Nikolay Aleksandrovich 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Институт неразрушающего контроля  |b Кафедра экологии и безопасности жизнедеятельности  |3 (RuTPU)RU\TPU\col\18720  |9 27170 
801 2 |a RU  |b 63413507  |c 20160825  |g RCR 
856 4 |u http://dx.doi.org/10.1007/s10517-015-3151-y 
942 |c CF